NM-2201

Add links
Source: Wikipedia, the free encyclopedia.
NM-2201
Legal status
Legal status
Identifiers
  • Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
JSmol)
  • FCCCCCN1C=C(C(OC2=C(C=CC=C3)C3=CC=C2)=O)C4=CC=CC=C41
  • InChI=1S/C24H22FNO2/c25-15-6-1-7-16-26-17-21(20-12-4-5-13-22(20)26)24(27)28-23-14-8-10-18-9-2-3-11-19(18)23/h2-5,8-14,17H,1,6-7,15-16H2
  • Key:PRGFSQYZCKCBQO-UHFFFAOYSA-N

NM-2201 (also known as CBL-2201 and NA-5F-PIC

affinity.[2][3][4][5]

Pharmacology

NM-2201 acts as a

CB2 cannabinoid receptors.[6] It has been linked to serious adverse events in users.[7]

Legal status

NM-2201 is specifically banned in Sweden,[8] Germany (Anlage II),[9] and Japan[10] but is also controlled in many other jurisdictions under analogue laws.

On May 30, 2018 the United States Drug Enforcement Administration, Department of Justice published a notice of intent to place NM-2201 and 4 other synthetic cannabinoids in schedule I of the Controlled Substances Act. This notice went into effect on June 29, 2018.[11]

Use

NM-2201 was linked to an incident in December 2015 where 25-30 people in Ocala, FL were taken to hospitals after experiencing seizures.[11]

See also

References

  1. doi:10.1002/dta.3403
    .
  2. PMID 26386336
    .
  3. ^ "NM-2201". Cayman Chemical. Retrieved 9 July 2015.
  4. PMID 26257831
    .
  5. PMID 25305529
    .
  6. PMID 27429655
    .
  7. PMID 28433979
    .
  8. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. Retrieved 9 July 2015.
  9. ^ "Gesetz über den Verkehr mit Betäubungsmitteln Anlage II". www.gesetze-im-internet.de (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved 24 October 2016.
  10. PMID 28286577
    .
  11. ^ a b "2018 - Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I". www.deadiversion.usdoj.gov. Retrieved 2018-06-15.
Retrieved from "https://en.wikipedia.org/w/index.php?title=NM-2201&oldid=1199236350"